Simple jQuery Dropdowns

Browsing by Author Charla Andrews

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
15-Apr-2013Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm; Robert M. Paris; Supamit Chunsutthiwat; Nakorn Premsri; Chawetsan Namwat; Chureeratana Bowonwatanuwong; Shuying S. Li; Jaranit Kaewkungkal; Rapee Trichavaroj; Nampueng Churikanont; Mark S. De Souza; Charla Andrews; Donald Francis; Elizabeth Adams; Jorge Flores; Sanjay Gurunathan; Jim Tartaglia; Robert J. O'Connell; Chirapa Eamsila; Sorachai Nitayaphan; Viseth Ngauy; Prasert Thongcharoen; Prayura Kunasol; Nelson L. Michael; Merlin L. Robb; Peter B. Gilbert; Jerome H. Kim; Thailand Ministry of Public Health; US Military HIV Research Program; Chonburi Regional Hospital; Fred Hutchinson Cancer Research Center; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Royal Thai Army
1-Jan-2014HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A. Prentice; Philip K. Ehrenberg; Karen M. Baldwin; Aviva Geretz; Charla Andrews; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Robert J. O'Connell; Merlin L. Robb; Jerome H. Kim; Nelson L. Michael; Rasmi Thomas; Walter Reed Army Institute of Research; HJF; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; Mahidol University
5-Apr-2012Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F. Haynes; Peter B. Gilbert; M. Juliana McElrath; Susan Zolla-Pazner; Georgia D. Tomaras; S. Munir Alam; David T. Evans; David C. Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua Xin Liao; Anthony L. DeVico; George K. Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L. Robb; Viseth Ngauy; Mark S. De Souza; Robert Paris; Guido Ferrari; Robert T. Bailer; Kelly A. Soderberg; Charla Andrews; Phillip W. Berman; Nicole Frahm; Stephen C. De Rosa; Michael D. Alpert; Nicole L. Yates; Xiaoying Shen; Richard A. Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; NYU School of Medicine; Harvard Medical School; Walter Reed Army Institute of Research; National Institute of Allergy and Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Royal Thai Army; Faculty of Medicine, Siriraj Hospital, Mahidol University; Mahidol University; Thailand Ministry of Public Health; University of California, Santa Cruz; University of Maryland School of Medicine; Rutgers New Jersey Medical School
1-Aug-2012Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsDavid C. Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S. De Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M. Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C. Labranche; Charla Andrews; Victoria R. Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G. Self; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L. Robb; Barton F. Haynes; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Armed Forces Research Institute of Medical Sciences, San Francisco; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; University of Alabama; Ministry of Public Health; Mahidol University; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Sanofi Pasteur
1-Jan-2014Performance of a redesigned HIV selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participantsOksana Penezina; Neil X. Krueger; Isaac R. Rodriguez-Chavez; Michael P. Busch; John Hural; Jerome H. Kim; Robert J. O'Connell; Eric Hunter; Said Aboud; Keith Higgins; Victor Kovalenko; David Clapham; David Crane; Andrew E. Levin; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Charla Andrews; William Kilembe; Etienne Karita; Susan Allen; Patricia Munseri; Agricola Joachim; Muhammad Bakari; Fred Mhalu; Eric Aris; Charlotta Nilsson; Gunnel Biberfeld; Merlin Robb; Mary Marovich; Eric Sandstrom; Immunetics, Inc.; National Institute of Dental and Craniofacial Research; Blood Systems Research Institute; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; Armed Forces Research Institute of Medical Sciences, Thailand; Emory University; Muhimbili University of Health and Allied Sciences; Global Solutions for Infectious Diseases; Thailand Ministry of Public Health; Mahidol University; Muhimbili National Hospital; Karolinska Institutet; Swedish Institute for Communicable Disease Control; HJF
19-Mar-2014Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccinesAmy W. Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne Sophie Dugast; Matthew K. Schoen; Morgane Rolland; Todd J. Suscovich; Alison E. Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S. De Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L. Michael; Jerome H. Kim; Chris Bailey-Kellogg; Margaret E. Ackerman; Galit Alter; Massachusetts Institute of Technology; Thayer School of Engineering at Dartmouth; Dartmouth College; Walter Reed Army Institute of Research; Duke University; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Global Solutions for Infectious Diseases
1-Nov-2012The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; NYU School of Medicine; Veterans Affairs NY Harbor Healthcare System; National Institute of Allergy and Infectious Diseases; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; Thailand Ministry of Public Health; Mahidol University; Walter Reed National Military Medical Center; Sanofi Pasteur; Global Solutions for Infectious Diseases; Los Alamos National Laboratory